Tag: Pharmaceutical industry patent expiration
Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research
Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir among pharmaceutical companies, investors, and researchers alike. This critical issue...
BREAKING NEWS
Reforming FDA Advisory Committee Policy for Conflict of Interest-Free Decisions
Peter J. Pitts, a distinguished figure in the realm of healthcare regulation, recently shared his insights on the critical issue of FDA Advisory Committee...
